Across TCGA pan-cancer cohorts, ELOCP36 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated ELOCP36 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher ELOCP36 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ELOCP36 expression acts as an unfavorable survival marker.

MESO are the cancer types where ELOCP36 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.130	0.557	.019	54	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: ELOCP36 tumor-vs-normal RNA expression · all ELOCP36 data types